ConductScience.org, home

Paper208459

5,6-Dihydro-5-azathymidine: in vitro antiviral properties against human herpesviruses.

Renis HE. Antimicrob Agents Chemother, 1978. Cited by 9 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. 5,6-Dihydro-5-azathymidine: in vitro antiviral properties against human herpesviruses. Papers, record 208459. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/208459

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
5,6-Dihydro-5-azathymidine: in vitro antiviral properties against human herpesviruses.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1978
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.59
iCite
Revised in PubMed
2021-05-26
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Renis HEH E

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
SimplexvirusMajor topic
ThymidineMajor topic
Animals
Humans
Rabbits
Time Factors
Vaccinia virus

Source PubMed

Download CSV of topics

References13

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114219080INHIBITION BY METABOLIC ANALOGUES OF PLAQUE FORMATION BY HERPES ZOSTER AND HERPES SIMPLEX VIRUSES.J Immunol1964https://conductscience.org/library/papers/14219080PubMed
214454445Clinical cure of herpes simplex keratitis by 5-iodo-2-deoxyuridine.Proc Soc Exp Biol Med1962https://conductscience.org/library/papers/14454445PubMed
314454436Use of 5-iodo-2'-deoxyuridine (IDU) in treatment of herpes simplex keratitis.Arch Ophthalmol1962https://conductscience.org/library/papers/14454436PubMed
4184048Pathogenesis of herpes simplex virus types 1 and 2 in mice after various routes of inoculation.Infect Immun1976https://conductscience.org/library/papers/184048PubMed
5212988A rational approach to the development of antiviral chemotherapy: alternative substrates of herpes simplex virus Type 1 (HSV-1) and Type 2 (HSV-2) thymidine kinase (TK).Ann N Y Acad Sci1977https://conductscience.org/library/papers/212988PubMed
6212984The selective inhibition of viral DNA synthesis by chemotherapeutic agents: an indicator of clinical usefulness?Ann N Y Acad Sci1977https://conductscience.org/library/papers/212984PubMed
75466741Comparison of cytotoxicity and antiviral activity of 1-beta-D-arabino-furanosyl-5-iodocytosine with related compounds.Cancer Res1970https://conductscience.org/library/papers/5466741PubMed
8856033Efficacy of 5,6-dihydro-5-azathymidine against cutaneous herpes simplex virus in hairless mice.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/856033PubMed
9856023Chemotherapy of genital herpes simplex virus type 2 infections of female hamsters.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/856023PubMed
10167186Selective inhibition of herpes simplex virus by 5-amino-2,5-dideoxy-5-iodouridine.J Virol1975https://conductscience.org/library/papers/167186PubMed
11167520Inhibition of herpes simplex virus replication by araT.Virology1975https://conductscience.org/library/papers/167520PubMed
12938547Nucleoside analogs with antiviral activity.Biochem Pharmacol1976https://conductscience.org/library/papers/938547PubMed
13197886Antiviral activity of arabinosylthymine in herpesviral replication: mechanism of action in vivo and in vitro.Antimicrob Agents Chemother1977https://conductscience.org/library/papers/197886PubMed

Download CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
426515Activities of 5,6-dihydro-5-azathymidine against herpes simplex virus infections in mice.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/426515PubMed
230783Growth inhibition by acycloguanosine of herpesviruses isolated from human infections.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/230783PubMed
224809Effect of 5-iodo-5'-amino-2',5'-dideoxyuridine on varicella-zoster virus in vitro.Antimicrob Agents Chemother1979https://conductscience.org/library/papers/224809PubMed
223163(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agent.Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/223163PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/208459

GET https://conductscience.org/api/papers/v1/208459/authors